Skip to main content

Seegene Licenses Multiplex Assay Technologies to BioMerieux for Food Safety Testing

NEW YORK (GenomeWeb News) – Seegene said today that BioMérieux has taken a license to its DPO and TOCE technologies for the development of multiplexed molecular tests for food safety.

Financial terms of the agreement were not disclosed.

Seegene's DPO (dual-priming oligonucleotide) and TOCE (tagging oligonucleotide capture and extension) technologies enable highly multiplexed assays based on real-time PCR.

DPO can be used to block extension of non-specifically primed templates, generating consistently high specificity, while TOCE enables simultaneous multiplexed assays by separating genes that have been amplified by real-time PCR technology based on differences in their melting temperatures, Seegene said.

"We believe that the adoption of our leading multiplexing technology will curtail future food contamination outbreaks, save lives, and help to grow this important market," Seegene CEO and CTO Jong-Yoon Chun said in a statement.

Seegene last year inked a similar licensing agreement for food safety testing with DuPont Nutrition & Health.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.